Citations (54)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Shiho Ito, Kyoko Miwa, Chiharu Hattori, Tetsuo Aida, Yoshimi Tsuchiya & Kazuhiko Mori. (2021) Highly sensitive in vitro cytokine release assay incorporating high-density preculture. Journal of Immunotoxicology 18:1, pages 136-143.
Read now
Read now
Osmond J D’Cruz, Sanjive Qazi, Larn Hwang, Kevin Ng & Vuong Trieu. (2018) Impact of targeting transforming growth factor β-2 with antisense OT-101 on the cytokine and chemokine profile in patients with advanced pancreatic cancer. OncoTargets and Therapy 11, pages 2779-2796.
Read now
Read now
Joseph M. Ryan, Jeffrey S. Wasser, Adam J. Adler & Anthony T. Vella. (2016) Enhancing the safety of antibody-based immunomodulatory cancer therapy without compromising therapeutic benefit: Can we have our cake and eat it too?. Expert Opinion on Biological Therapy 16:5, pages 655-674.
Read now
Read now
Nicolas Poirier, Caroline Mary, Stephanie Le Bas-Bernardet, Veronique Daguin, Lyssia Belarif, Melanie Chevalier, Jeremy Hervouet, David Minault, Simon Ville, Vianney Charpy, Gilles Blancho & Bernard Vanhove. (2014) Advantages of Papio anubis for preclinical testing of immunotoxicity of candidate therapeutic antagonist antibodies targeting CD28. mAbs 6:3, pages 697-706.
Read now
Read now
Articles from other publishers (50)
Shayne C. Gad. 2024. Encyclopedia of Toxicology. Encyclopedia of Toxicology
7
10
.
Kevin Portmann, Aline Linder, Nicole Oelgarth & Klaus Eyer. (2023) Single-cell deep phenotyping of cytokine release unmasks stimulation-specific biological signatures and distinct secretion dynamics. Cell Reports Methods 3:7, pages 100502.
Crossref
Crossref
Susan Miller, Walter Moos, Barbara Munk, Stephen Munk, Charles Hart & David Spellmeyer. 2023. Managing the Drug Discovery Process. Managing the Drug Discovery Process
513
527
.
Richard Tavaré, Makenzie Danton, Jason T. Giurleo, Sosina Makonnen, Carlos Hickey, Tomas C. Arnold, Marcus P. Kelly, Fanny Fredriksson, Karina Bruestle, Aynur Hermann, Erica Ullman, Kurt H. Edelmann, Terra Potocky, Drew Dudgeon, Nikunj B. Bhatt, Mikhail Doubrovin, Thomas Barry, Christos A. Kyratsous, Cagan Gurer, Naxin Tu, Hans Gartner, Andrew Murphy, Lynn E. Macdonald, Jon Popke, Akiva Mintz, Adam Griesemer, William C. Olson, Gavin Thurston, Dangshe Ma & Jessica R. Kirshner. (2022) Immuno-PET Monitoring of Lymphocytes Using the CD8-Specific Antibody REGN5054. Cancer Immunology Research 10:10, pages 1190-1209.
Crossref
Crossref
Mark F. Maurer, Katherine E. Lewis, Joseph L. Kuijper, Dan Ardourel, Chelsea J. Gudgeon, Siddarth Chandrasekaran, Sherri L. Mudri, Kayla N. Kleist, Chris Navas, Martin F. Wolfson, Mark W. Rixon, Ryan Swanson, Stacey R. Dillon, Steven D. Levin, Yengo Raymond Kimbung, Masato Akutsu, Derek T. Logan, Björn Walse, Kristine M. Swiderek & Stanford L. Peng. (2022) The engineered CD80 variant fusion therapeutic davoceticept combines checkpoint antagonism with conditional CD28 costimulation for anti-tumor immunity. Nature Communications 13:1.
Crossref
Crossref
Nicolas Frances, Marina Bacac, Katharine Bray-French, François Christen, Heather Hinton, Elisabeth Husar, Elizabeth Quackenbush, Martin Schäfer, Eginhard Schick, Arthur Van De Vyver & Wolfgang F. Richter. (2022) Novel in Vivo and in Vitro Pharmacokinetic/Pharmacodynamic-Based Human Starting Dose Selection for Glofitamab. Journal of Pharmaceutical Sciences 111:4, pages 1208-1218.
Crossref
Crossref
Natasha Helleberg Madsen, Monika Gad & Jesper Larsen. (2022) Development of a flow cytometry-based potency assay for prediction of cytokine storms induced by biosimilar monoclonal antibodies. Journal of Immunological Methods 502, pages 113231.
Crossref
Crossref
Donald J. AbrahamVincent L. Reynolds, Matthew M. Abernathy, Ronee B. Baracani, Javed A. Bhalli, LaRonda Morford, Meredith A. Steeves & Wei Wang. 2003. Burger's Medicinal Chemistry and Drug Discovery. Burger's Medicinal Chemistry and Drug Discovery
1
85
.
M. Eltahir, E. Fletcher, L. Dynesius, J.L. Jarblad, M. Lord, I. Laurén, M. Zekarias, X. Yu, M.S. Cragg, C. Hammarström, K.H. Levedahl, M. Höglund, G. Ullenhag, M. Mattsson & S.M. Mangsbo. (2021) Profiling of donor-specific immune effector signatures in response to rituximab in a human whole blood loop assay using blood from CLL patients. International Immunopharmacology 90, pages 107226.
Crossref
Crossref
Amanda Hanson, Kutlu Elpek, Ellen Duong, Lindsey Shallberg, Martin Fan, Calvin Johnson, Matthew Wallace, George R. Mabry, Stephen Sazinsky, Lauren Pepper, Chengyi J. Shu, Sriram Sathyanarayanan, Sarah Zuerndorfer, Tyler Simpson, Monica Gostissa, Michael Briskin, Deborah Law, Jennifer Michaelson & Christopher J. Harvey. (2020) ICOS agonism by JTX-2011 (vopratelimab) requires initial T cell priming and Fc cross-linking for optimal T cell activation and anti-tumor immunity in preclinical models. PLOS ONE 15:9, pages e0239595.
Crossref
Crossref
Chunting Ye, Hongyuan Yang, Mingshan Cheng, Leonard D. Shultz, Dale L. Greiner, Michael A. Brehm & James G. Keck. (2020) A rapid, sensitive, and reproducible in vivo PBMC humanized murine model for determining therapeutic‐related cytokine release syndrome. The FASEB Journal 34:9, pages 12963-12975.
Crossref
Crossref
Asako Harada, Akifumi Shioda, Tatsuya Ikuno, Yoshika Iwata, Hirotake Shiraiwa, Tetsuya Wakabayashi, Yuji Sano & Masayuki Mishima. (2020) In vitro toxicological support to establish specification limit for anti-CD3 monospecific impurity in a bispecific T cell engager drug, ERY974. Toxicology in Vitro 66, pages 104841.
Crossref
Crossref
Janelle C. Waite, Bei Wang, Lauric Haber, Aynur Hermann, Erica Ullman, Xuan Ye, Drew Dudgeon, Rabih SlimDharani K. AjithdossStephen J. GodinIlyssa RamosQi Wu, Erin OswaldPatrick Poon, Jacquelynn Golubov, Devon Grote, Jennifer StellaArpita Pawashe, Jennifer Finney, Evan Herlihy, Hassan Ahmed, Vishal KamatAmanda Dorvilliers, Elizabeth NavarroJenny Xiao, Julie Kim, Shao Ning YangJacqueline WarsawClarissa Lett, Lauren CanovaTeresa SchulenburgRandi FosterPamela Krueger, Elena Garnova, Ashique Rafique, Robert BabbGang ChenNicole Stokes Oristian, Chia-Jen Siao, Christopher Daly, Cagan GurerJoel Martin, Lynn Macdonald, Douglas MacDonald, William Poueymirou, Eric SmithIsrael LowyGavin ThurstonWilliam Olson, John C. LinMatthew A. Sleeman, George D. YancopoulosAndrew J. Murphy & Dimitris Skokos. (2020) Tumor-targeted CD28 bispecific antibodies enhance the antitumor efficacy of PD-1 immunotherapy. Science Translational Medicine 12:549.
Crossref
Crossref
Dimitris Skokos, Janelle C. Waite, Lauric Haber, Alison Crawford, Aynur Hermann, Erica Ullman, Rabih SlimStephen GodinDharani AjithdossXuan Ye, Bei Wang, Qi Wu, Ilyssa RamosArpita Pawashe, Lauren CanovaKristin VazzanaPriyanka RamEvan Herlihy, Hassan Ahmed, Erin OswaldJacquelynn Golubov, Patrick Poon, Lauren HavelDanica Chiu, Miguel Lazo, Kathleen Provoncha, Kevin Yu, Julie KimJacqueline J. WarsawNicole Stokes Oristian, Chia-Jen Siao, Drew Dudgeon, Tammy HuangTerra PotockyJoel Martin, Douglas MacDonald, Adelekan OyejideAshique Rafique, William Poueymirou, Jessica R. Kirshner, Eric SmithWilliam Olson, John LinGavin ThurstonMatthew A. Sleeman, Andrew J. Murphy & George D. Yancopoulos. (2020) A class of costimulatory CD28-bispecific antibodies that enhance the antitumor activity of CD3-bispecific antibodies. Science Translational Medicine 12:525.
Crossref
Crossref
Hangyi Yan, Kenrick M. Semple, Carlos M. Gonzaléz & Kristina E. Howard. (2019) Bone marrow-liver-thymus (BLT) immune humanized mice as a model to predict cytokine release syndrome. Translational Research 210, pages 43-56.
Crossref
Crossref
Joannes A. A. Reijers, Karen E. Malone, Jeffrey J. Bajramovic, Richard Verbeek, Jacobus Burggraaf & Matthijs Moerland. (2019) Adverse immunostimulation caused by impurities: The dark side of biopharmaceuticals. British Journal of Clinical Pharmacology 85:7, pages 1418-1426.
Crossref
Crossref
Alan S. Bass, Michael K. Pugsley, Frederick Sannajust, Takashi Yoshinaga & Jean-Pierre Valentin. (2019) Response of safety pharmacologists to challenges arising from the rapidly evolving changes in the pharmaceutical industry. Journal of Pharmacological and Toxicological Methods 98, pages 106593.
Crossref
Crossref
Hangyi Yan, Bhagyashree Bhagwat, David Sanden, Aarron Willingham, Alick Tan, Alan D. Knapton, James L. Weaver & Kristina E. Howard. (2019) Evaluation of a TGN1412 analogue using in vitro assays and two immune humanized mouse models. Toxicology and Applied Pharmacology 372, pages 57-69.
Crossref
Crossref
Enping Hong, Justin Halman, Ankit Shah, Edward Cedrone, Nguyen Truong, Kirill Afonin & Marina Dobrovolskaia. (2019) Toll-Like Receptor-Mediated Recognition of Nucleic Acid Nanoparticles (NANPs) in Human Primary Blood Cells. Molecules 24:6, pages 1094.
Crossref
Crossref
Ali Roghanian, Richard J Stopforth, Lekh N Dahal & Mark S Cragg. (2018) New revelations from an old receptor: Immunoregulatory functions of the inhibitory Fc gamma receptor, FcγRIIB (CD32B). Journal of Leukocyte Biology 103:6, pages 1077-1088.
Crossref
Crossref
P. L. A. van Daele. (2018) Complicaties van behandeling met biologicals. Bijblijven 34:2, pages 160-166.
Crossref
Crossref
D. Gouty, C. C. Cai, X. Y. Cai, A. Kasinath, V. Kumar, S. Alvandkouhi, J. Yang, S. Pederson, B. Babbitt, D. Peritt, A. Rudy, V. Koppenburg, A. Dasilva, M. Ullmann, S. Liu & C. Satterwhite. (2017) Recommendations for the Development and Validation of Neutralizing Antibody Assays in Support of Biosimilar Assessment. The AAPS Journal 20:1.
Crossref
Crossref
Erika A.K. Fletcher, Mohamed Eltahir, Frida Lindqvist, Jonas Rieth, Gunilla Törnqvist, Justyna Leja-Jarblad & Sara M. Mangsbo. (2018) Extracorporeal human whole blood in motion, as a tool to predict first-infusion reactions and mechanism-of-action of immunotherapeutics. International Immunopharmacology 54, pages 1-11.
Crossref
Crossref
M.S. Piche, W.J. Freebern & U. Herbrand. 2018. Comprehensive Toxicology. Comprehensive Toxicology
361
375
.
Kirsten M. Mease, Amy L. Kimzey & Janice A. Lansita. (2017) Biomarkers for nonclinical infusion reactions in marketed biotherapeutics and considerations for study design. Current Opinion in Toxicology 4, pages 1-15.
Crossref
Crossref
Arathi Kizhedath, Simon Wilkinson & Jarka Glassey. (2016) Applicability of predictive toxicology methods for monoclonal antibody therapeutics: status Quo and scope. Archives of Toxicology 91:4, pages 1595-1612.
Crossref
Crossref
Michiko Takakura, Minoru Tada & Akiko Ishii-Watabe. (2017) Development of cell-based assay for predictively evaluating the FcγR-mediated human immune cell activation by therapeutic monoclonal antibodies. Biochemical and Biophysical Research Communications 485:1, pages 189-194.
Crossref
Crossref
Maël Lemoine. (2017) Animal extrapolation in preclinical studies: An analysis of the tragic case of TGN1412. Studies in History and Philosophy of Science Part C: Studies in History and Philosophy of Biological and Biomedical Sciences 61, pages 35-45.
Crossref
Crossref
Alyssa R. Martin, Ross A. Pollack, Adam Capoferri, Richard F. Ambinder, Christine M. Durand & Robert F. Siliciano. (2017) Rapamycin-mediated mTOR inhibition uncouples HIV-1 latency reversal from cytokine-associated toxicity. Journal of Clinical Investigation 127:2, pages 651-656.
Crossref
Crossref
Adam Seidelin Hey. 2017. Recombinant Antibodies for Infectious Diseases. Recombinant Antibodies for Infectious Diseases
265
294
.
Haleh Saber, Ramadevi Gudi, Michael Manning, Emily Wearne & John K. Leighton. (2016) An FDA oncology analysis of immune activating products and first-in-human dose selection. Regulatory Toxicology and Pharmacology 81, pages 448-456.
Crossref
Crossref
Nut Koonrungsesomboon, Junjira Laothavorn & Juntra Karbwang. (2016) Ethical considerations and challenges in first-in-human research. Translational Research 177, pages 6-18.
Crossref
Crossref
Christine Grimaldi, Deborah Finco, Madeline M. Fort, Daniel Gliddon, Kirsty Harper, Whitney S. Helms, Jane A. Mitchell, Raegan O’Lone, Stanley T. Parish, Marie-Soleil Piche, Daniel M. Reed, Gabriele Reichmann, Patricia C. Ryan, Richard Stebbings & Mindi Walker. (2016) Cytokine release: A workshop proceedings on the state-of-the-science, current challenges and future directions. Cytokine 85, pages 101-108.
Crossref
Crossref
J. WhritenourS. CasinghinoM. CollingeX. Zhu. (2016) Nonclinical Tools to Assess Risk of Drug Hypersensitivity Reactions. Annual Review of Pharmacology and Toxicology 56:1, pages 561-576.
Crossref
Crossref
J.L. Bussiere. 2016. Reference Module in Biomedical Sciences. Reference Module in Biomedical Sciences.
S. Vessillier, D. Eastwood, B. Fox, J. Sathish, S. Sethu, T. Dougall, S.J. Thorpe, R. Thorpe & R. Stebbings. (2015) Cytokine release assays for the prediction of therapeutic mAb safety in first-in man trials — Whole blood cytokine release assays are poorly predictive for TGN1412 cytokine storm. Journal of Immunological Methods 424, pages 43-52.
Crossref
Crossref
Lucette Doessegger & Maria Longauer Banholzer. (2015) Clinical development methodology for infusion-related reactions with monoclonal antibodies. Clinical & Translational Immunology 4:7, pages e39.
Crossref
Crossref
Daniel M. Reed, Koralia E. Paschalaki, Richard D. Starke, Nura A. Mohamed, Giles Sharp, Bernard Fox, David Eastwood, Adrian Bristow, Christina Ball, Sandrine Vessillier, Trevor T. Hansel, Susan J. Thorpe, Anna M. Randi, Richard Stebbings & Jane A. Mitchell. (2015) An autologous endothelial cell:peripheral blood mononuclear cell assay that detects cytokine storm responses to biologics. The FASEB Journal 29:6, pages 2595-2602.
Crossref
Crossref
Steven L. Rosinski, Rainer Storb, Roland K. Strong, George E. Sale, Diane M. Stone, Mesfin M. Gewe, Della J. Friend, V. Kraig Abrams, Julie Randolph-Habecker & Scott S. Graves. (2015) Anti-CD28 Antibody-Initiated Cytokine Storm in Canines. Transplantation Direct 1:2, pages 1-11.
Crossref
Crossref
Jennifer H. Martin & Albert Ferro. (2015) From an evolutionary perspective, all ‘new’ antimicrobial targets are old: time to think outside the box. British Journal of Clinical Pharmacology 79:2, pages 165-167.
Crossref
Crossref
Adnan Nasir. 2015. Clinical Dermatology Trials 101. Clinical Dermatology Trials 101
1
20
.
Jan Willem van der Laan, Carla Herberts, David Jones, Susan J Thorpe, Richard Stebbings & Robin Thorpe. 2014. Molecular Immunotoxicology. Molecular Immunotoxicology
189
208
.
Rafael A. Ponce. 2014. Molecular Immunotoxicology. Molecular Immunotoxicology
159
188
.
Alexander Batista-Duharte, Deivys Portuondo, O Pérez & Iracilda Zeppone Carlos. (2014) Systemic immunotoxicity reactions induced by adjuvanted vaccines. International Immunopharmacology 20:1, pages 170-180.
Crossref
Crossref
D. Finco, C. Grimaldi, M. Fort, M. Walker, A. Kiessling, B. Wolf, T. Salcedo, R. Faggioni, A. Schneider, A. Ibraghimov, S. Scesney, D. Serna, R. Prell, R. Stebbings & P.K. Narayanan. (2014) Cytokine release assays: Current practices and future directions. Cytokine 66:2, pages 143-155.
Crossref
Crossref
Diane Williamson. (2014) Approaches to Modelling the Human Immune Response in Transition of Candidates from Research to Development. Journal of Immunology Research 2014, pages 1-6.
Crossref
Crossref
J. Fain & S.C. Gad. 2014. Encyclopedia of Toxicology. Encyclopedia of Toxicology
521
522
.
Suzanne J. Suchard, Patricia M. Davis, Selena Kansal, Dawn K. Stetsko, Ruth Brosius, James Tamura, Lumelle Schneeweis, James Bryson, Theodora Salcedo, Haiqing Wang, Zheng Yang, Catherine A. Fleener, Olga Ignatovich, Christopher Plummer, Steven Grant & Steven G. Nadler. (2013) A Monovalent Anti-Human CD28 Domain Antibody Antagonist: Preclinical Efficacy and Safety. The Journal of Immunology 191:9, pages 4599-4610.
Crossref
Crossref
Babette Wolf, Hannah Morgan, Frank Brennan, Jennifer Krieg, Zaahira Gani, Stewart Jones & Andrea Kiessling. (2013) Response to the Letter to the Editor by Susan Thorpe et al.: How predictive are in vitro assays for cytokine release syndrome in vivo? A comparison of methods reveals worrying differences in sensitivity and frequency of response. Cytokine 64:1, pages 473-475.
Crossref
Crossref
Christina Ball, Bernard Fox, Simon Hufton, Giles Sharp, Stephen Poole, Richard Stebbings, David Eastwood, Lucy Findlay, Paul W. H. I. Parren, Robin Thorpe, Adrian Bristow & Susan J. Thorpe. (2012) Antibody C Region Influences TGN1412-like Functional Activity In Vitro. The Journal of Immunology 189:12, pages 5831-5840.
Crossref
Crossref